NMRA
Neumora Therapeutics, Inc.
0.55$
-7.7%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +0.0% | +412.4% | +10.4% | +12.5% | -5.5% | -67.0% | |
| – | – | +155.2% | +94.2% | +107.8% | +132.0% | -25.3% | |
| – | +0.0% | +114.9% | -86.2% | – | – | – | |
| – | – | – | – | – | – | -101.9% | |
| – | +0.0% | -37.2% | -37.5% | -77.1% | -100.0% | – | |
| – | +0.0% | -92.7% | +20,464.6% | – | -209.6% | – | |
| – | – | -100.0% | – | – | -100.0% | – | |
| – | +0.0% | -100.0% | – | – | – | – | |
| – | +0.0% | +27.6% | -60.6% | +100.4% | -90.7% | +256.8% | |
| – | +0.0% | +13.1% | -176.9% | – | -274.3% | – | |
| – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.